bug-bounty532
xss362
exploit257
google242
rce196
facebook177
microsoft156
web3122
malware121
writeup119
cve115
open-source91
csrf89
apple86
account-takeover82
browser73
sqli69
cloudflare63
ai-agents63
phishing63
dos62
privilege-escalation56
ssrf53
pentest51
reverse-engineering50
supply-chain48
tool46
auth-bypass44
privacy44
oauth41
aws38
idor38
ctf37
llm37
cloud37
opinion35
race-condition34
lfi34
automation33
node33
machine-learning32
infrastructure31
code-generation31
clickjacking30
react29
cors28
access-control27
info-disclosure27
subdomain-takeover26
performance-optimization24
0
2/10
Stanford Medicine researchers developed a novel intranasal vaccine that protects against diverse respiratory viruses, bacteria, and allergens by mimicking T cell signals that sustain innate immune responses for months, rather than using traditional antigen-specific approaches. The vaccine combines toll-like receptor stimuli with a harmless antigen to create a feedback loop between innate and adaptive immunity, providing broad cross-protection in mice against SARS-CoV-2, coronaviruses, hospital-acquired pathogens, and dust mites.
vaccine-development
innate-immunity
adaptive-immunity
respiratory-infections
intranasal-vaccine
universal-vaccine
toll-like-receptors
sars-cov-2
coronavirus
bacterial-infections
allergen-protection
immunology
t-cell-signaling
cytokines
dendritic-cells
Stanford Medicine
Bali Pulendran
Haibo Zhang
Science
GLA-3M-052-LS+OVA
SARS-CoV-2
Staphylococcus aureus
Acinetobacter baumannii
Edward Jenner